Skip to main content

OrbiMed Advisors LLC's Form 4 filing

Disc Medicine, Inc. (IRON) · filed Dec 20, 2023

Accession no.
0000947871-23-001168
Filed
Dec 20, 2023, 6:28 PM ET
Trade date
Dec 18, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $102.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
OrbiMed Advisors LLCCIK 0001055951Director
OrbiMed Capital GP VI LLCCIK 0001682115Director
OrbiMed Genesis GP LLCCIK 0001808744Director
OrbiMed Capital GP VIII LLCCIK 0001845804Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 18, 2023Common StockMOption exerciseAcquired+1,724$38.00+$65,5121,724DirectDuplicate filing
Dec 18, 2023Common StockSSaleDisposed−1,724$59.24−$102,129.760DirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 18, 2023Common StockMOption exerciseDisposed−1,724$0.00$00DirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)